In vitro anticancer activity of docetaxel-loaded micelles based on poly(ethylene oxide)-poly(epsilon-caprolactone) block copolymers: Do nanocarrier properties have a role?
In this paper we have investigated the behavior of core-shell poly(ethylene oxide)-poly(epsilon-caprolactone) (PEO-PCL) micelles derived from copolymers with linear triblock (TR) and 4-arm star-diblock (ST) architectures for the delivery of docetaxel (DTX). DTX was loaded inside micelles (DTX-TR m a...
Saved in:
Published in | Journal of controlled release Vol. 148; no. 2; pp. 255 - 263 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Kidlington
Elsevier B.V
01.12.2010
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | In this paper we have investigated the behavior of core-shell poly(ethylene oxide)-poly(epsilon-caprolactone) (PEO-PCL) micelles derived from copolymers with linear triblock (TR) and 4-arm star-diblock (ST) architectures for the delivery of docetaxel (DTX). DTX was loaded inside micelles (DTX-TR
m and DTX-ST
m) with high efficiency and released slowly for more than two weeks. DTX-loaded micelles based on both copolymers had very similar properties in terms of mean size, zeta potential, loading ability and release rate in buffered saline. However, the stability of DTX-ST
m was very poor in aqueous media with proteins resulting in a strong and progressive aggregation. We studied the effect of increasing concentrations of free DTX or DTX-loaded micelles on growth inhibition of human breast MCF-7 and MDA-MB468 and prostate PC3 and DU145 adenocarcinoma cell lines. DTX-loaded TR micelles induced cell growth inhibition similarly to free DTX whereas DTX-ST
m showed lower cytotoxicity. On the other hand, by normalizing IC
50 values for the actual amount of DTX released from micelles in the medium, DTX-loaded ST micelles became more active than free DTX in all cell lines tested. Both free DTX and DTX-loaded TR micelles displayed a significantly lower cytotoxic activity in G
2/M phase synchronized cells, whereas cytotoxicity of DTX-loaded ST micelles did not change. Cytotoxicity was related to micelle stability, uptake and release rate in cell culture media. Our results suggest that for a correct interpretation of cytotoxicity of nanocarriers, the evaluation of their behavior in biologically relevant conditions is of utmost importance to select proper systems for further
in vivo testing.
Biodegradable micelles delivering an anticancer drug and made of poly(ethylene oxide)/poly(epsilon-caprolactone) block copolymers with different architectures share similar technological features while showing very different cytotoxicity.
[Display omitted] |
---|---|
AbstractList | In this paper we have investigated the behavior of core-shell poly(ethylene oxide)-poly(epsilon-caprolactone) (PEO-PCL) micelles derived from copolymers with linear triblock (TR) and 4-arm star-diblock (ST) architectures for the delivery of docetaxel (DTX). DTX was loaded inside micelles (DTX-TR
m and DTX-ST
m) with high efficiency and released slowly for more than two weeks. DTX-loaded micelles based on both copolymers had very similar properties in terms of mean size, zeta potential, loading ability and release rate in buffered saline. However, the stability of DTX-ST
m was very poor in aqueous media with proteins resulting in a strong and progressive aggregation. We studied the effect of increasing concentrations of free DTX or DTX-loaded micelles on growth inhibition of human breast MCF-7 and MDA-MB468 and prostate PC3 and DU145 adenocarcinoma cell lines. DTX-loaded TR micelles induced cell growth inhibition similarly to free DTX whereas DTX-ST
m showed lower cytotoxicity. On the other hand, by normalizing IC
50 values for the actual amount of DTX released from micelles in the medium, DTX-loaded ST micelles became more active than free DTX in all cell lines tested. Both free DTX and DTX-loaded TR micelles displayed a significantly lower cytotoxic activity in G
2/M phase synchronized cells, whereas cytotoxicity of DTX-loaded ST micelles did not change. Cytotoxicity was related to micelle stability, uptake and release rate in cell culture media. Our results suggest that for a correct interpretation of cytotoxicity of nanocarriers, the evaluation of their behavior in biologically relevant conditions is of utmost importance to select proper systems for further
in vivo testing.
Biodegradable micelles delivering an anticancer drug and made of poly(ethylene oxide)/poly(epsilon-caprolactone) block copolymers with different architectures share similar technological features while showing very different cytotoxicity.
[Display omitted] In this paper we have investigated the behavior of core-shell poly(ethylene oxide)-poly(epsilon-caprolactone) (PEO-PCL) micelles derived from copolymers with linear triblock (TR) and 4-arm star-diblock (ST) architectures for the delivery of docetaxel (DTX). DTX was loaded inside micelles (DTX-TR sub(m) and DTX-ST sub(m)) with high efficiency and released slowly for more than two weeks. DTX-loaded micelles based on both copolymers had very similar properties in terms of mean size, zeta potential, loading ability and release rate in buffered saline. However, the stability of DTX-ST sub(m) was very poor in aqueous media with proteins resulting in a strong and progressive aggregation. We studied the effect of increasing concentrations of free DTX or DTX-loaded micelles on growth inhibition of human breast MCF-7 and MDA-MB468 and prostate PC3 and DU145 adenocarcinoma cell lines. DTX-loaded TR micelles induced cell growth inhibition similarly to free DTX whereas DTX-ST sub(m) showed lower cytotoxicity. On the other hand, by normalizing IC sub(50) values for the actual amount of DTX released from micelles in the medium, DTX-loaded ST micelles became more active than free DTX in all cell lines tested. Both free DTX and DTX-loaded TR micelles displayed a significantly lower cytotoxic activity in G sub(2)/M phase synchronized cells, whereas cytotoxicity of DTX-loaded ST micelles did not change. Cytotoxicity was related to micelle stability, uptake and release rate in cell culture media. Our results suggest that for a correct interpretation of cytotoxicity of nanocarriers, the evaluation of their behavior in biologically relevant conditions is of utmost importance to select proper systems for further in vivo testing. In this paper we have investigated the behavior of core-shell poly(ethylene oxide)-poly(epsilon-caprolactone) (PEO-PCL) micelles derived from copolymers with linear triblock (TR) and 4-arm star-diblock (ST) architectures for the delivery of docetaxel (DTX). DTX was loaded inside micelles (DTX-TR(m) and DTX-ST(m)) with high efficiency and released slowly for more than two weeks. DTX-loaded micelles based on both copolymers had very similar properties in terms of mean size, zeta potential, loading ability and release rate in buffered saline. However, the stability of DTX-ST(m) was very poor in aqueous media with proteins resulting in a strong and progressive aggregation. We studied the effect of increasing concentrations of free DTX or DTX-loaded micelles on growth inhibition of human breast MCF-7 and MDA-MB468 and prostate PC3 and DU145 adenocarcinoma cell lines. DTX-loaded TR micelles induced cell growth inhibition similarly to free DTX whereas DTX-ST(m) showed lower cytotoxicity. On the other hand, by normalizing IC(50) values for the actual amount of DTX released from micelles in the medium, DTX-loaded ST micelles became more active than free DTX in all cell lines tested. Both free DTX and DTX-loaded TR micelles displayed a significantly lower cytotoxic activity in G(2)/M phase synchronized cells, whereas cytotoxicity of DTX-loaded ST micelles did not change. Cytotoxicity was related to micelle stability, uptake and release rate in cell culture media. Our results suggest that for a correct interpretation of cytotoxicity of nanocarriers, the evaluation of their behavior in biologically relevant conditions is of utmost importance to select proper systems for further in vivo testing. |
Author | Ungaro, Francesca Zappavigna, Silvia Abbruzzese, Alberto Caraglia, Michele Maglio, Giovanni Ostacolo, Luisanna Marra, Monica Quaglia, Fabiana |
Author_xml | – sequence: 1 givenname: Luisanna surname: Ostacolo fullname: Ostacolo, Luisanna organization: Department of Pharmaceutical and Toxicological Chemistry, University of Naples Federico II, Via D. Montesano 49, 80131, Naples – Italy – sequence: 2 givenname: Monica surname: Marra fullname: Marra, Monica organization: Department of Biochemistry and Biophysics, II University of Naples, Via Costantinopoli 16, 80138, Naples – Italy – sequence: 3 givenname: Francesca surname: Ungaro fullname: Ungaro, Francesca organization: Department of Pharmaceutical and Toxicological Chemistry, University of Naples Federico II, Via D. Montesano 49, 80131, Naples – Italy – sequence: 4 givenname: Silvia surname: Zappavigna fullname: Zappavigna, Silvia organization: Department of Biochemistry and Biophysics, II University of Naples, Via Costantinopoli 16, 80138, Naples – Italy – sequence: 5 givenname: Giovanni surname: Maglio fullname: Maglio, Giovanni organization: Department of Chemistry “Paolo Corradini”, University of Naples Federico II, Via Cintia, 80126, Naples – Italy – sequence: 6 givenname: Fabiana surname: Quaglia fullname: Quaglia, Fabiana email: quaglia@unina.it organization: Department of Pharmaceutical and Toxicological Chemistry, University of Naples Federico II, Via D. Montesano 49, 80131, Naples – Italy – sequence: 7 givenname: Alberto surname: Abbruzzese fullname: Abbruzzese, Alberto organization: Department of Biochemistry and Biophysics, II University of Naples, Via Costantinopoli 16, 80138, Naples – Italy – sequence: 8 givenname: Michele surname: Caraglia fullname: Caraglia, Michele organization: Department of Biochemistry and Biophysics, II University of Naples, Via Costantinopoli 16, 80138, Naples – Italy |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23504602$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/20816710$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc1u1DAQgC1URLeFRwD5gqCHLHZiO0kvFSp_lSpxgbPl2BPVi2MHO7vqPhMvyax2gSMXWx594_n5LshZTBEIecnZmjOu3m3WG5tihrCuGcZYt2ZMPSEr3rVNJfpenpEVcl3VKNmfk4tSNowx2Yj2GTmvWcdVy9mK_LqLdOeXnKiJi7cmWsjU2MVjcE_TSF2ysJhHCFVIxoGjk7cQAhQ6mILPFOmcwv4tLA_7ABFoevQOrqpjcC4-pFhZM-cU8Fuc4YoOIdkf1KYDMkEu1_RDotHEZE3OHusjPENePBZ5MDughmI23DwnT0cTCrw43Zfk-6eP326_VPdfP9_dvr-vrKjVUkmmnOtcI0AMvQMAUfccRiVVi2druGKtrFXHezmKhtVNL5pBCuFqJxQbRHNJ3hz_xT5-bqEsevLlMLSJkLZF91LIntVCIimPpM2plAyjnrOfTN5rzvRBk97okyZ90KRZp1ET5r06VdgOE7i_WX-8IPD6BJhiTRgzivHlH9dIhr3WyN0cOcB97HB3ulgPKNH5DHbRLvn_tPIbxH24QQ |
CODEN | JCREEC |
CitedBy_id | crossref_primary_10_1002_adhm_201300519 crossref_primary_10_1016_j_nano_2011_08_012 crossref_primary_10_1016_j_jcis_2024_03_154 crossref_primary_10_1186_s12951_016_0239_0 crossref_primary_10_1002_advs_201600285 crossref_primary_10_1016_j_jconrel_2011_06_012 crossref_primary_10_3390_ma16062298 crossref_primary_10_1016_j_nano_2020_102267 crossref_primary_10_1080_1061186X_2016_1245309 crossref_primary_10_1002_pat_3556 crossref_primary_10_1016_j_progpolymsci_2015_11_002 crossref_primary_10_1016_j_ijpharm_2015_03_067 crossref_primary_10_1021_acsabm_4c00638 crossref_primary_10_1021_acsabm_8b00675 crossref_primary_10_1021_acs_biomac_1c01022 crossref_primary_10_1016_j_hsr_2023_100101 crossref_primary_10_1016_j_ijpharm_2019_118486 crossref_primary_10_1016_j_ijpharm_2023_122711 crossref_primary_10_18632_oncotarget_9771 crossref_primary_10_3390_polym15051179 crossref_primary_10_1039_C5RA21067D crossref_primary_10_3390_molecules23020497 crossref_primary_10_1038_srep28373 crossref_primary_10_1038_srep29460 crossref_primary_10_1002_pi_4896 crossref_primary_10_1016_j_apmt_2023_101865 crossref_primary_10_1016_j_jconrel_2014_03_026 crossref_primary_10_3390_polym13183133 crossref_primary_10_1016_j_ijpharm_2015_07_012 crossref_primary_10_1016_j_ijpharm_2013_05_003 crossref_primary_10_1002_macp_201400043 crossref_primary_10_1021_acs_molpharmaceut_7b00177 crossref_primary_10_1016_j_msec_2015_12_049 crossref_primary_10_3390_polym6030634 crossref_primary_10_1016_j_biopha_2011_09_010 crossref_primary_10_1002_mabi_201100083 crossref_primary_10_1517_17425247_2012_696606 crossref_primary_10_1021_acsami_6b01611 crossref_primary_10_1016_j_progpolymsci_2015_10_009 crossref_primary_10_1016_j_ijpharm_2014_03_009 crossref_primary_10_1007_s10549_019_05301_0 crossref_primary_10_1016_j_biomaterials_2015_02_108 crossref_primary_10_1038_srep34069 crossref_primary_10_1016_j_biomaterials_2014_01_040 crossref_primary_10_1021_acsomega_7b00829 crossref_primary_10_1517_17425247_2014_913568 crossref_primary_10_1080_21691401_2017_1307214 crossref_primary_10_1002_jps_23418 crossref_primary_10_1016_j_jconrel_2012_12_026 |
Cites_doi | 10.1634/theoncologist.10-90003-30 10.1002/jbm.a.31804 10.1016/j.jconrel.2009.11.012 10.1615/CritRevTherDrugCarrierSyst.v25.i6.10 10.1021/la0531998 10.1007/s00345-002-0275-2 10.1016/j.biomaterials.2008.09.035 10.1016/j.jconrel.2009.04.010 10.1080/15583720701455079 10.1016/j.biomaterials.2005.05.042 10.1002/jps.21037 10.1016/S0168-3659(02)00212-2 10.2174/138161206779026263 10.1016/j.ejpb.2007.08.014 10.1517/14656566.9.15.2603 10.1097/CAD.0b013e3280113338 10.1016/j.ejpb.2006.11.010 10.1021/mp800049w 10.1021/mp800137z 10.1016/j.ejpb.2007.02.024 10.1007/s10549-007-9591-y 10.1093/jb/mvg097 10.1016/0142-9612(96)85755-3 10.1016/j.biomaterials.2007.05.026 10.1016/S0169-409X(98)00100-8 10.2165/00003088-199936020-00002 10.1038/nrd2614 |
ContentType | Journal Article |
Copyright | 2010 Elsevier B.V. 2015 INIST-CNRS Copyright © 2010 Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2010 Elsevier B.V. – notice: 2015 INIST-CNRS – notice: Copyright © 2010 Elsevier B.V. All rights reserved. |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QO 8FD FR3 P64 |
DOI | 10.1016/j.jconrel.2010.08.006 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Biotechnology Research Abstracts Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Engineering Research Database Biotechnology Research Abstracts Technology Research Database Biotechnology and BioEngineering Abstracts |
DatabaseTitleList | Engineering Research Database MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1873-4995 |
EndPage | 263 |
ExternalDocumentID | 10_1016_j_jconrel_2010_08_006 20816710 23504602 S0168365910006619 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K --M .GJ .~1 0R~ 1B1 1RT 1~. 1~5 29K 3O- 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM AABNK AABXZ AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATCM AAXUO AAYOK ABFNM ABFRF ABJNI ABMAC ABOCM ABXDB ABYKQ ABZDS ACDAQ ACGFO ACGFS ACIUM ACNNM ACRLP ADBBV ADEZE ADMUD AEBSH AEFWE AEKER AENEX AEZYN AFKWA AFRZQ AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC C45 CS3 D-I DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HMT HVGLF HZ~ IHE J1W KOM M34 M41 MO0 N9A O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 R2- RIG RNS ROL RPZ SCC SDF SDG SDP SES SEW SPC SPCBC SPT SSM SSP SSZ T5K TEORI WUQ ~G- ABPIF ABPTK IQODW AAHBH AAXKI AKRWK CGR CUY CVF ECM EIF NPM AAYXX AFJKZ CITATION 7QO 8FD FR3 P64 |
ID | FETCH-LOGICAL-c426t-506dd8d34e4b9deee4291ef6567ef67a16075268195f43023943b544d2d460b43 |
IEDL.DBID | AIKHN |
ISSN | 0168-3659 |
IngestDate | Sat Oct 26 01:31:58 EDT 2024 Thu Sep 26 15:43:44 EDT 2024 Sat Sep 28 07:53:44 EDT 2024 Sun Oct 22 16:09:10 EDT 2023 Fri Feb 23 02:28:55 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Poly(ethylene oxide)-poly(epsilon-caprolactone) Cytotoxicity Stability Micelles Docetaxel Antineoplastic agent Lactone copolymer Pharmaceutical technology Micelle In vitro Biological activity Ethylene oxide polymer Caprolactone copolymer Cyclic ether polymer Taxane derivatives Antimitotic Physicochemical properties Block copolymer Nanotechnology |
Language | English |
License | CC BY 4.0 Copyright © 2010 Elsevier B.V. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c426t-506dd8d34e4b9deee4291ef6567ef67a16075268195f43023943b544d2d460b43 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
PMID | 20816710 |
PQID | 954590245 |
PQPubID | 23462 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_954590245 crossref_primary_10_1016_j_jconrel_2010_08_006 pubmed_primary_20816710 pascalfrancis_primary_23504602 elsevier_sciencedirect_doi_10_1016_j_jconrel_2010_08_006 |
PublicationCentury | 2000 |
PublicationDate | 2010-12-01 |
PublicationDateYYYYMMDD | 2010-12-01 |
PublicationDate_xml | – month: 12 year: 2010 text: 2010-12-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Kidlington |
PublicationPlace_xml | – name: Kidlington – name: Netherlands |
PublicationTitle | Journal of controlled release |
PublicationTitleAlternate | J Control Release |
PublicationYear | 2010 |
Publisher | Elsevier B.V Elsevier |
Publisher_xml | – name: Elsevier B.V – name: Elsevier |
References | Letchford, Liggins, Burt (bb0095) 2008; 3 Gopferich (bb0100) 1996; 2 Lee, Chung, Im, Park, Kim, Kim, Rha, Lee, Ro (bb0035) 2008; 2 Quaglia, Ostacolo, Nese, Canciello, De Rosa, Ungaro, Palumbo, La Rotonda, Maglio (bb0080) 2008; 3 LiL (bb0090) 2008; 4 Petri-Fink, Steitz, Finka, Salaklang, Hofmann (bb0070) 2008; 1 Quaglia, Ostacolo, Mazzaglia, Villari, Zaccaria, Sciortino (bb0120) 2009; 3 Berry, Eisenberger (bb0055) 2005 Calabro, Sternberg (bb0045) 2002; 3 Dong, Feng (bb0115) 2007; 28 Harush-Frenkel, Altschuler, Benita (bb0135) 2008; 6 Tong, Cheng (bb0015) 2007; 3 Mikhail, Allen (bb0030) 2009; 3 Caraglia, Marra, Giuberti, D'Alessandro, Baldi, Tassone, Venuta, Tagliaferri, Abbruzzese (bb0085) 2003; 6 Carstens, de Jong, van Nostrum, Kemmink, Verrijk, de Leede, Crommelin, Hennink (bb0105) 2008; 3 Davis, Chen, Shin (bb0060) 2008; 9 Fonseca, Simoes, Gaspar (bb0125) 2002; 2 Gaucher, Leroux (bb0025) 2010 Engels, Mathot, Verweij (bb0005) 2007; 2 Aliabadi, Brocks, Lavasanifar (bb0110) 2005; 35 Xu, Gullotti, Tong, Highley, Errabelli, Hasan, Cheng, Kohane, Yeo (bb0130) 2009; 1 Liu, Zeng, Allen (bb0075) 2007; 3 Trubetskoy (bb0020) 1999; 1–3 Savic, Azzam, Eisenberg, Maysinger (bb0065) 2006; 8 Clarke, Rivory (bb0040) 1999; 2 Saloustros, Mavroudis, Georgoulias (bb0050) 2008; 15 Liu, Lee, Allen (bb0010) 2006; 36 Caraglia (10.1016/j.jconrel.2010.08.006_bb0085) 2003; 6 Savic (10.1016/j.jconrel.2010.08.006_bb0065) 2006; 8 LiL (10.1016/j.jconrel.2010.08.006_bb0090) 2008; 4 Quaglia (10.1016/j.jconrel.2010.08.006_bb0120) 2009; 3 Saloustros (10.1016/j.jconrel.2010.08.006_bb0050) 2008; 15 Davis (10.1016/j.jconrel.2010.08.006_bb0060) 2008; 9 Liu (10.1016/j.jconrel.2010.08.006_bb0010) 2006; 36 Gopferich (10.1016/j.jconrel.2010.08.006_bb0100) 1996; 2 Gaucher (10.1016/j.jconrel.2010.08.006_bb0025) 2010 Xu (10.1016/j.jconrel.2010.08.006_bb0130) 2009; 1 Dong (10.1016/j.jconrel.2010.08.006_bb0115) 2007; 28 Petri-Fink (10.1016/j.jconrel.2010.08.006_bb0070) 2008; 1 Liu (10.1016/j.jconrel.2010.08.006_bb0075) 2007; 3 Carstens (10.1016/j.jconrel.2010.08.006_bb0105) 2008; 3 Clarke (10.1016/j.jconrel.2010.08.006_bb0040) 1999; 2 Letchford (10.1016/j.jconrel.2010.08.006_bb0095) 2008; 3 Fonseca (10.1016/j.jconrel.2010.08.006_bb0125) 2002; 2 Tong (10.1016/j.jconrel.2010.08.006_bb0015) 2007; 3 Lee (10.1016/j.jconrel.2010.08.006_bb0035) 2008; 2 Engels (10.1016/j.jconrel.2010.08.006_bb0005) 2007; 2 Berry (10.1016/j.jconrel.2010.08.006_bb0055) 2005 Mikhail (10.1016/j.jconrel.2010.08.006_bb0030) 2009; 3 Aliabadi (10.1016/j.jconrel.2010.08.006_bb0110) 2005; 35 Harush-Frenkel (10.1016/j.jconrel.2010.08.006_bb0135) 2008; 6 Trubetskoy (10.1016/j.jconrel.2010.08.006_bb0020) 1999; 1–3 Calabro (10.1016/j.jconrel.2010.08.006_bb0045) 2002; 3 Quaglia (10.1016/j.jconrel.2010.08.006_bb0080) 2008; 3 |
References_xml | – volume: 3 start-page: 158 year: 2002 end-page: 166 ident: bb0045 article-title: New drugs and new approaches for the treatment of metastatic urothelial cancer publication-title: World J. Urol. contributor: fullname: Sternberg – volume: 1 start-page: 190 year: 2009 end-page: 201 ident: bb0130 article-title: Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited publication-title: Mol. Pharm. contributor: fullname: Yeo – volume: 2 start-page: 273 year: 2002 end-page: 286 ident: bb0125 article-title: Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity publication-title: J. Control. Release contributor: fullname: Gaspar – volume: 28 start-page: 4154 year: 2007 end-page: 4160 ident: bb0115 article-title: In vitro and in vivo evaluation of methoxy polyethylene glycol-polylactide (MPEG-PLA) nanoparticles for small-molecule drug chemotherapy publication-title: Biomaterials contributor: fullname: Feng – volume: 2 start-page: 241 year: 2008 end-page: 250 ident: bb0035 article-title: Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer publication-title: Breast Cancer Res. Treat. contributor: fullname: Ro – volume: 3 start-page: 1179 year: 2008 end-page: 1190 ident: bb0095 article-title: Solubilization of hydrophobic drugs by methoxy poly(ethylene glycol)-block-polycaprolactone diblock copolymer micelles: theoretical and experimental data and correlations publication-title: J. Pharm. Sci. contributor: fullname: Burt – volume: 15 start-page: 2603 year: 2008 end-page: 2616 ident: bb0050 article-title: Paclitaxel and docetaxel in the treatment of breast cancer publication-title: Expert Opin. Pharmacother. contributor: fullname: Georgoulias – volume: 6 start-page: 485 year: 2008 end-page: 544 ident: bb0135 article-title: Nanoparticle-cell interactions: drug delivery implications publication-title: Crit. Rev. Ther. Drug Carrier Syst. contributor: fullname: Benita – volume: 2 start-page: 103 year: 1996 end-page: 114 ident: bb0100 article-title: Mechanisms of polymer degradation and erosion publication-title: Biomaterials contributor: fullname: Gopferich – volume: 3 start-page: 214 year: 2009 end-page: 223 ident: bb0030 article-title: Block copolymer micelles for delivery of cancer therapy: transport at the whole body, tissue and cellular levels publication-title: J. Control. Release contributor: fullname: Allen – volume: 1–3 start-page: 81 year: 1999 end-page: 88 ident: bb0020 article-title: Polymeric micelles as carriers of diagnostic agents publication-title: Adv. Drug Deliv. Rev. contributor: fullname: Trubetskoy – year: 2010 ident: bb0025 article-title: Polyester-based micelles and nanoparticles for the parenteral delivery of taxanes publication-title: J. Control. Release contributor: fullname: Leroux – volume: 35 start-page: 7251 year: 2005 end-page: 7259 ident: bb0110 article-title: Polymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistribution publication-title: Biomaterials contributor: fullname: Lavasanifar – volume: 9 start-page: 771 year: 2008 end-page: 782 ident: bb0060 article-title: Nanoparticle therapeutics: an emerging treatment modality for cancer publication-title: Nat. Rev. Drug Discov. contributor: fullname: Shin – volume: 2 start-page: 99 year: 1999 end-page: 114 ident: bb0040 article-title: Clinical pharmacokinetics of docetaxel publication-title: Clin. Pharmacokinet. contributor: fullname: Rivory – volume: 3 start-page: 345 year: 2007 end-page: 381 ident: bb0015 article-title: Anticancer polymeric nanomedicines publication-title: Polym. Rev. contributor: fullname: Cheng – volume: 1 start-page: 129 year: 2008 end-page: 137 ident: bb0070 article-title: Effect of cell media on polymer coated superparamagnetic iron oxide nanoparticles (SPIONs): colloidal stability, cytotoxicity, and cellular uptake studies publication-title: Eur. J. Pharm. Biopharm. contributor: fullname: Hofmann – volume: 8 start-page: 3570 year: 2006 end-page: 3578 ident: bb0065 article-title: Assessment of the integrity of poly(caprolactone)-b-poly(ethylene oxide) micelles under biological conditions: a fluorogenic-based approach publication-title: Langmuir contributor: fullname: Maysinger – volume: 2 start-page: 95 year: 2007 end-page: 103 ident: bb0005 article-title: [PEGylated (immuno)liposomal DTX, DTX-fibrinogen-coated olive oil droplets, DTX encapsulated nanoparticle-aptamer bioconjugates, submicronic dispersion formulation] to develop an alternative, solvent-free, delivery form for DTX characterized by increased efficacy and decreased toxicity. Alternative drug formulations of DTX: a review. publication-title: Anticancer Drugs contributor: fullname: Verweij – volume: 3 start-page: 596 year: 2008 end-page: 606 ident: bb0105 article-title: The effect of core composition in biodegradable oligomeric micelles as taxane formulations publication-title: Eur. J. Pharm. Biopharm. contributor: fullname: Hennink – volume: 3 start-page: 374 year: 2009 end-page: 382 ident: bb0120 article-title: The intracellular effects of non-ionic amphiphilic cyclodextrin nanoparticles in the delivery of anticancer drugs publication-title: Biomaterials contributor: fullname: Sciortino – volume: 6 start-page: 757 year: 2003 end-page: 765 ident: bb0085 article-title: The eukaryotic initiation factor 5A is involved in the regulation of proliferation and apoptosis induced by interferon-alpha and EGF in human cancer cells publication-title: J. Biochem. contributor: fullname: Abbruzzese – volume: 4 start-page: 496 year: 2008 end-page: 504 ident: bb0090 article-title: Huang, Pharmacokinetics and biodistribution of nanoparticles publication-title: Mol. Pharm. contributor: fullname: LiL – volume: 3 start-page: 563 year: 2008 end-page: 574 ident: bb0080 article-title: Micelles based on amphiphilic PCL-PEO triblock and star-shaped diblock copolymers: potential in drug delivery applications publication-title: J. Biomed. Mater. Res. A contributor: fullname: Maglio – start-page: 30 year: 2005 end-page: 39 ident: bb0055 article-title: Achieving treatment goals for hormone-refractory prostate cancer with chemotherapy publication-title: Oncologist contributor: fullname: Eisenberger – volume: 3 start-page: 309 year: 2007 end-page: 319 ident: bb0075 article-title: In vivo fate of unimers and micelles of a poly(ethylene glycol)-block-poly(caprolactone) copolymer in mice following intravenous administration publication-title: Eur. J. Pharm. Biopharm. contributor: fullname: Allen – volume: 36 start-page: 4685 year: 2006 end-page: 4701 ident: bb0010 article-title: Formulation of drugs in block copolymer micelles: drug loading and release publication-title: Curr. Pharm. Des. contributor: fullname: Allen – start-page: 30 year: 2005 ident: 10.1016/j.jconrel.2010.08.006_bb0055 article-title: Achieving treatment goals for hormone-refractory prostate cancer with chemotherapy publication-title: Oncologist doi: 10.1634/theoncologist.10-90003-30 contributor: fullname: Berry – volume: 3 start-page: 563 year: 2008 ident: 10.1016/j.jconrel.2010.08.006_bb0080 article-title: Micelles based on amphiphilic PCL-PEO triblock and star-shaped diblock copolymers: potential in drug delivery applications publication-title: J. Biomed. Mater. Res. A doi: 10.1002/jbm.a.31804 contributor: fullname: Quaglia – year: 2010 ident: 10.1016/j.jconrel.2010.08.006_bb0025 article-title: Polyester-based micelles and nanoparticles for the parenteral delivery of taxanes publication-title: J. Control. Release doi: 10.1016/j.jconrel.2009.11.012 contributor: fullname: Gaucher – volume: 6 start-page: 485 year: 2008 ident: 10.1016/j.jconrel.2010.08.006_bb0135 article-title: Nanoparticle-cell interactions: drug delivery implications publication-title: Crit. Rev. Ther. Drug Carrier Syst. doi: 10.1615/CritRevTherDrugCarrierSyst.v25.i6.10 contributor: fullname: Harush-Frenkel – volume: 8 start-page: 3570 year: 2006 ident: 10.1016/j.jconrel.2010.08.006_bb0065 article-title: Assessment of the integrity of poly(caprolactone)-b-poly(ethylene oxide) micelles under biological conditions: a fluorogenic-based approach publication-title: Langmuir doi: 10.1021/la0531998 contributor: fullname: Savic – volume: 3 start-page: 158 year: 2002 ident: 10.1016/j.jconrel.2010.08.006_bb0045 article-title: New drugs and new approaches for the treatment of metastatic urothelial cancer publication-title: World J. Urol. doi: 10.1007/s00345-002-0275-2 contributor: fullname: Calabro – volume: 3 start-page: 374 year: 2009 ident: 10.1016/j.jconrel.2010.08.006_bb0120 article-title: The intracellular effects of non-ionic amphiphilic cyclodextrin nanoparticles in the delivery of anticancer drugs publication-title: Biomaterials doi: 10.1016/j.biomaterials.2008.09.035 contributor: fullname: Quaglia – volume: 3 start-page: 214 year: 2009 ident: 10.1016/j.jconrel.2010.08.006_bb0030 article-title: Block copolymer micelles for delivery of cancer therapy: transport at the whole body, tissue and cellular levels publication-title: J. Control. Release doi: 10.1016/j.jconrel.2009.04.010 contributor: fullname: Mikhail – volume: 3 start-page: 345 year: 2007 ident: 10.1016/j.jconrel.2010.08.006_bb0015 article-title: Anticancer polymeric nanomedicines publication-title: Polym. Rev. doi: 10.1080/15583720701455079 contributor: fullname: Tong – volume: 35 start-page: 7251 year: 2005 ident: 10.1016/j.jconrel.2010.08.006_bb0110 article-title: Polymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistribution publication-title: Biomaterials doi: 10.1016/j.biomaterials.2005.05.042 contributor: fullname: Aliabadi – volume: 3 start-page: 1179 year: 2008 ident: 10.1016/j.jconrel.2010.08.006_bb0095 article-title: Solubilization of hydrophobic drugs by methoxy poly(ethylene glycol)-block-polycaprolactone diblock copolymer micelles: theoretical and experimental data and correlations publication-title: J. Pharm. Sci. doi: 10.1002/jps.21037 contributor: fullname: Letchford – volume: 2 start-page: 273 year: 2002 ident: 10.1016/j.jconrel.2010.08.006_bb0125 article-title: Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity publication-title: J. Control. Release doi: 10.1016/S0168-3659(02)00212-2 contributor: fullname: Fonseca – volume: 36 start-page: 4685 year: 2006 ident: 10.1016/j.jconrel.2010.08.006_bb0010 article-title: Formulation of drugs in block copolymer micelles: drug loading and release publication-title: Curr. Pharm. Des. doi: 10.2174/138161206779026263 contributor: fullname: Liu – volume: 3 start-page: 596 year: 2008 ident: 10.1016/j.jconrel.2010.08.006_bb0105 article-title: The effect of core composition in biodegradable oligomeric micelles as taxane formulations publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2007.08.014 contributor: fullname: Carstens – volume: 15 start-page: 2603 year: 2008 ident: 10.1016/j.jconrel.2010.08.006_bb0050 article-title: Paclitaxel and docetaxel in the treatment of breast cancer publication-title: Expert Opin. Pharmacother. doi: 10.1517/14656566.9.15.2603 contributor: fullname: Saloustros – volume: 2 start-page: 95 year: 2007 ident: 10.1016/j.jconrel.2010.08.006_bb0005 article-title: [PEGylated (immuno)liposomal DTX, DTX-fibrinogen-coated olive oil droplets, DTX encapsulated nanoparticle-aptamer bioconjugates, submicronic dispersion formulation] to develop an alternative, solvent-free, delivery form for DTX characterized by increased efficacy and decreased toxicity. Alternative drug formulations of DTX: a review. publication-title: Anticancer Drugs doi: 10.1097/CAD.0b013e3280113338 contributor: fullname: Engels – volume: 3 start-page: 309 year: 2007 ident: 10.1016/j.jconrel.2010.08.006_bb0075 article-title: In vivo fate of unimers and micelles of a poly(ethylene glycol)-block-poly(caprolactone) copolymer in mice following intravenous administration publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2006.11.010 contributor: fullname: Liu – volume: 4 start-page: 496 year: 2008 ident: 10.1016/j.jconrel.2010.08.006_bb0090 article-title: Huang, Pharmacokinetics and biodistribution of nanoparticles publication-title: Mol. Pharm. doi: 10.1021/mp800049w contributor: fullname: LiL – volume: 1 start-page: 190 year: 2009 ident: 10.1016/j.jconrel.2010.08.006_bb0130 article-title: Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited publication-title: Mol. Pharm. doi: 10.1021/mp800137z contributor: fullname: Xu – volume: 1 start-page: 129 year: 2008 ident: 10.1016/j.jconrel.2010.08.006_bb0070 article-title: Effect of cell media on polymer coated superparamagnetic iron oxide nanoparticles (SPIONs): colloidal stability, cytotoxicity, and cellular uptake studies publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2007.02.024 contributor: fullname: Petri-Fink – volume: 2 start-page: 241 year: 2008 ident: 10.1016/j.jconrel.2010.08.006_bb0035 article-title: Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer publication-title: Breast Cancer Res. Treat. doi: 10.1007/s10549-007-9591-y contributor: fullname: Lee – volume: 6 start-page: 757 year: 2003 ident: 10.1016/j.jconrel.2010.08.006_bb0085 article-title: The eukaryotic initiation factor 5A is involved in the regulation of proliferation and apoptosis induced by interferon-alpha and EGF in human cancer cells publication-title: J. Biochem. doi: 10.1093/jb/mvg097 contributor: fullname: Caraglia – volume: 2 start-page: 103 year: 1996 ident: 10.1016/j.jconrel.2010.08.006_bb0100 article-title: Mechanisms of polymer degradation and erosion publication-title: Biomaterials doi: 10.1016/0142-9612(96)85755-3 contributor: fullname: Gopferich – volume: 28 start-page: 4154 year: 2007 ident: 10.1016/j.jconrel.2010.08.006_bb0115 article-title: In vitro and in vivo evaluation of methoxy polyethylene glycol-polylactide (MPEG-PLA) nanoparticles for small-molecule drug chemotherapy publication-title: Biomaterials doi: 10.1016/j.biomaterials.2007.05.026 contributor: fullname: Dong – volume: 1–3 start-page: 81 year: 1999 ident: 10.1016/j.jconrel.2010.08.006_bb0020 article-title: Polymeric micelles as carriers of diagnostic agents publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/S0169-409X(98)00100-8 contributor: fullname: Trubetskoy – volume: 2 start-page: 99 year: 1999 ident: 10.1016/j.jconrel.2010.08.006_bb0040 article-title: Clinical pharmacokinetics of docetaxel publication-title: Clin. Pharmacokinet. doi: 10.2165/00003088-199936020-00002 contributor: fullname: Clarke – volume: 9 start-page: 771 year: 2008 ident: 10.1016/j.jconrel.2010.08.006_bb0060 article-title: Nanoparticle therapeutics: an emerging treatment modality for cancer publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd2614 contributor: fullname: Davis |
SSID | ssj0005347 |
Score | 2.298327 |
Snippet | In this paper we have investigated the behavior of core-shell poly(ethylene oxide)-poly(epsilon-caprolactone) (PEO-PCL) micelles derived from copolymers with... |
SourceID | proquest crossref pubmed pascalfrancis elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 255 |
SubjectTerms | Antineoplastic Agents - chemistry Antineoplastic Agents - metabolism Antineoplastic Agents - pharmacology Biological and medical sciences Biological Transport Breast Neoplasms - metabolism Breast Neoplasms - pathology Cell Line, Tumor Cell Proliferation - drug effects Chemistry, Pharmaceutical Cytotoxicity Delayed-Action Preparations Docetaxel Dose-Response Relationship, Drug Drug Carriers Drug Compounding Drug Stability Female General pharmacology Humans Inhibitory Concentration 50 Kinetics Male Medical sciences Micelles Nanoparticles Pharmaceutical technology. Pharmaceutical industry Pharmacology. Drug treatments Poly(ethylene oxide)-poly(epsilon-caprolactone) Polyesters - chemistry Polyesters - metabolism Prostatic Neoplasms - metabolism Prostatic Neoplasms - pathology Solubility Stability Taxoids - chemistry Taxoids - metabolism Taxoids - pharmacology |
Title | In vitro anticancer activity of docetaxel-loaded micelles based on poly(ethylene oxide)-poly(epsilon-caprolactone) block copolymers: Do nanocarrier properties have a role? |
URI | https://dx.doi.org/10.1016/j.jconrel.2010.08.006 https://www.ncbi.nlm.nih.gov/pubmed/20816710 https://search.proquest.com/docview/954590245 |
Volume | 148 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Na9wwEBXp5lIopd_dpF3mUEID8e7alhy7lxLShk0LIdAEcjOyNabeGtvYTshe-of6Jzvjj5gcQqEXHwSyZY0079mamSfEB4I4Ow5cZWFie_SBohIrIGJiGeMbPsaRcdQGyJ55q0v57UpdbYnjIReGwyp739_59NZb9y2LfjYXZZoufhBZ8V1PBXaLm1z6c5vu7vgTsX10-n11NkZ6uLLLmvZ8izuMiTyL9XxNn50VZn2QFwdWeg9B1JNS1zRxSad48TAlbaHp5Jl42nNKOOqG_VxsYf5C7J13Rak3B3Ax5ljVB7AH52O56s1L8ec0h5u0qQqgSWanGGMFnO7AqhJQJGAI4hp9i5mVFdqgAVawzzKsgSHQQJFDWWSbj0g2JwxDKG5Tg_tW11jWaVbkVqzpNTIW98lxHyKC0F8Qs0DDhn-cf4IvBeQ6J2CtWEIPSj4jqLjYK_zUNwgaOAzy8ytxefL14nhl9RIOVkzQ31hq6bHVXYkyCgwiEvzZmBCJPKTroebydlxwxg5UIt1Wp92NlJTGMdJbRtJ9LSY5DeytAN9Xka0T4jtJLAM_0Zr8ESqk_kEU-2Yq5oPVwrKr1BEOIWzrsDdzyGYOWXhz6U2FP9g2vLfkQkKTf3Wd3VsLdw90XMUnzc5UwLA4QtqvbBWdY3FdhwFR1oDPu6fiTbdoxs4sgkKMb-f_B7YrHjt38TbvxKSprvE9saYmmolH89_2rN8bfwHr4Bom |
link.rule.ids | 315,783,787,4509,24128,27936,27937,45597,45691 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Na9wwEBUhObRQSr-7SZvOoYQG4ux6LTtWLyWkDbtNugS6gdyMbI2pt8Y2thOyv6l_sjP-iMkhFHrxQSAsa6R5T9bMPCE-EsTZkXJcC2PbowOKG1uKiIlljG_4GkdGYRMgu_Bml_L7lXu1IU76XBgOq-x8f-vTG2_dtYy72RwXSTL-SWTFdzxX2Q1ucunPLWIDinbn1vH8bLYYIj0c2WZNe77FHYZEnvHqcEXHzhLTLsiLAyu9hyDqSaErmri4Vbx4mJI20HT6TDztOCUct8N-LjYweyH2Ltqi1OsDWA45VtUB7MHFUK56_VL8mWdwk9RlDjTJ7BQjLIHTHVhVAvIYDEFcrW8xtdJcGzTACvZpihUwBBrIMyjydP0JyeaEYQj5bWJw32obiypJ88yKNH1GyuI-Ge5DSBD6GyIWaFjzj_PP8DWHTGcErCVL6EHBdwQlF3uFX_oGQQOHQX55JS5Pvy1PZlYn4WBFBP215U48trojUYbKICLBn40xkcgjeh5pLm_HBWds5cbSaXTandCV0kyN9CahdF6LzYwG9laA77uhrWPiO3EklR9rTf4IXaT-Kox8MxKHvdWCoq3UEfQhbKugM3PAZg5YeHPijYTf2za4t-QCQpN_dd29txbuXjh1XL5pno4E9IsjoP3KVtEZ5tdVoIiyKr7vHok37aIZOrMICjG-7f8f2AfxaLb8cR6czxdnO-Lx9C725p3YrMtrfE8Mqg53ux3yF7uGHBo |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In+vitro+anticancer+activity+of+docetaxel-loaded+micelles+based+on+poly%28ethylene+oxide%29-poly%28epsilon-caprolactone%29+block+copolymers%3A+Do+nanocarrier+properties+have+a+role%3F&rft.jtitle=Journal+of+controlled+release&rft.au=Ostacolo%2C+Luisanna&rft.au=Marra%2C+Monica&rft.au=Ungaro%2C+Francesca&rft.au=Zappavigna%2C+Silvia&rft.date=2010-12-01&rft.issn=0168-3659&rft.volume=148&rft.issue=2&rft.spage=255&rft.epage=263&rft_id=info:doi/10.1016%2Fj.jconrel.2010.08.006&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0168-3659&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0168-3659&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0168-3659&client=summon |